Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The clinical outcomes of idiopathic optic neuritis with no light perception in 21 eyes].
White-matter lesions drive deep gray-matter atrophy in early multiple sclerosis: support from structural MRI.
The perceptions of people with multiple sclerosis about the NHS provision of physiotherapy services.
Charcot-Marie-Tooth disease: Frequency of genetic subtypes in a German neuromuscular center population.
Evaluation of an albumin-binding gadolinium contrast agent in multiple sclerosis.
Venous Hemodynamic Insufficiency Severity Score variation after endovascular treatment of chronic cerebrospinal venous insufficiency.
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
Neuropsychological Performance, Brain Imaging, and Driving Violations in Multiple Sclerosis.
Wheelchair design for people with neuromuscular disability.
Decreased levels of repulsive guidance molecule A in association with beneficial effects of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients.
Seasonal vitamin D changes and the impact on health risk assessment.
Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice.
Adoptive transfer of cytokine-induced immunomodulatory adult microglia attenuates experimental autoimmune encephalomyelitis in DBA/1 mice.
Long-term suppression of EAE relapses by pharmacological impairment of epitope spreading.
Adaptive personalized training games for individual and collaborative rehabilitation of people with multiple sclerosis.
[Every fifth case of multiple sclerosis is familial.]
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Quantitative PCR Analysis of DNA Aptamer Pharmacokinetics in Mice.
Experimental protocol of a randomized controlled clinical trial investigating exercise, subclinical atherosclerosis, and walking mobility in persons with multiple sclerosis.
Emotional dysfunctions in neurodegenerative diseases.
Patient expression of emotions and neurologist responses in first multiple sclerosis consultations.
Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats.
Transverse myelitis in a patient with primary antiphospholipid syndrome.
Pages
« first
‹ previous
…
488
489
490
491
492
493
494
495
496
…
next ›
last »